A new client hired Trophic to define its core messaging and differentiate itself from other players in the virotherapy and greater immuno-oncology space to ensure a successful industry debut that would make a splash and set the tone for future business development.
Trophic launched the project with a strategic kickoff meeting to define the company’s vision, positioning statement, competitor landscape, and key messaging tones, creating a clear blueprint for communications.
From these insights, we crafted a new boilerplate and distinctive name that captured the company’s ethos, ensuring clarity, credibility, and differentiation in a competitive market.
Partnering with the client and a web developer, we built a modern website timed with the Series A launch, maximizing visibility and establishing the company as a strong new player in biotech.
Trophic successfully led the efforts to launch the company’s new webpage and ensure that its unique corporate story and name were represented in an equally stand-alone website. The company received overwhelmingly positive feedback on its launch and became an attractive biotech to watch as a biotech harnessing the power of arena viruses to create novel antivirus therapeutics for cancer.